Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lama H Nazer

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacy|January 21, 2019
Cost-effective analysis of low- versus high-dose colistin in the treatment of multi-drug resistant pneumonia in Saudi ArabiaLama H Nazer, Jennifer Le
The Canadian Journal of Hospital Pharmacy|May 11, 2017
Health Care and Pharmacy Practice in JordanLama H Nazer, Haitham Tuffaha
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 24, 2016
Optimizing colistin dosing: Is a loading dose necessary?Lama H Nazer, Nadine Anabtawi
Journal of Pharmacy Practice|April 27, 2016
A Program to Increase Research Productivity Among Hospital PharmacistsLama H Nazer, Haitham Tuffaha, Saad Jaddoua
Pharmacology Research & Perspectives|March 11, 2021
Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factorsLama H Nazer, Aseel K AbuSara, Yasmeen Kamal
The Annals of Pharmacotherapy|March 22, 2014
Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter baumanniiMohammad Al-Shaer, Lama H Nazer, Mazen Kherallah
Journal of Pharmacy Practice|December 10, 2013
Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomesLama H Nazer, Feras Hawari, Taghreed Al-Najjar
Journal of Intensive Care Medicine|July 25, 2018
Evaluating the Predictive Value of Lactate in Patients With Cancer Having Septic ShockLama H Nazer, Dalia Rimawi, Feras I Hawari
Journal of Critical Care|May 27, 2019
Intensive Care Unit readmissions- separate entity or a disease continuumAseel K AbuSara, Lama H Nazer, Feras I Hawari
Journal of Critical Care|February 17, 2019
ICU readmission of patients with cancer: Incidence, risk factors and mortalityAseel K AbuSara, Lama H Nazer, Feras I Hawari
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacy|January 21, 2019
Cost-effective analysis of low- versus high-dose colistin in the treatment of multi-drug resistant pneumonia in Saudi ArabiaLama H Nazer, Jennifer Le
The Canadian Journal of Hospital Pharmacy|May 11, 2017
Health Care and Pharmacy Practice in JordanLama H Nazer, Haitham Tuffaha
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 24, 2016
Optimizing colistin dosing: Is a loading dose necessary?Lama H Nazer, Nadine Anabtawi
Journal of Pharmacy Practice|April 27, 2016
A Program to Increase Research Productivity Among Hospital PharmacistsLama H Nazer, Haitham Tuffaha, Saad Jaddoua
Pharmacology Research & Perspectives|March 11, 2021
Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factorsLama H Nazer, Aseel K AbuSara, Yasmeen Kamal
The Annals of Pharmacotherapy|March 22, 2014
Rifampicin as adjunct to colistin therapy in the treatment of multidrug-resistant Acinetobacter baumanniiMohammad Al-Shaer, Lama H Nazer, Mazen Kherallah
Journal of Pharmacy Practice|December 10, 2013
Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomesLama H Nazer, Feras Hawari, Taghreed Al-Najjar
Journal of Intensive Care Medicine|July 25, 2018
Evaluating the Predictive Value of Lactate in Patients With Cancer Having Septic ShockLama H Nazer, Dalia Rimawi, Feras I Hawari
Journal of Critical Care|May 27, 2019
Intensive Care Unit readmissions- separate entity or a disease continuumAseel K AbuSara, Lama H Nazer, Feras I Hawari
Journal of Critical Care|February 17, 2019
ICU readmission of patients with cancer: Incidence, risk factors and mortalityAseel K AbuSara, Lama H Nazer, Feras I Hawari
Pageof 5